Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Good morning. We’ve got a lot of news to get into again today, and if you want to subscribe to read all of it, STAT is running a promo right now that gives you half off an annual subscription. Check it out here.
The need-to-know this morning
- Amgen earnings, reported Tuesday night, are here.
RFK Jr. cancels U.S. investment in mRNA vaccines
Health secretary Robert F. Kennedy Jr. last night announced that the government’s emergency preparedness agency, BARDA, will no longer fund work on messenger RNA vaccines.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
